Predictors of response to aromatase inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of response to aromatase inhibitors

Published:2007-08 Issue:1-5 Volume:106 Page:49-54
ISSN:0960-0760
Container-title:The Journal of Steroid Biochemistry and Molecular Biology
language:en
Short-container-title:The Journal of Steroid Biochemistry and Molecular Biology

Author:

Anderson Helen,Bulun Serdar,Smith Ian,Dowsett Mitch

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Endocrinology,Molecular Biology,Molecular Medicine,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference20 articles.

1. Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial;Baum;Lancet,2002

2. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer;Thürlimann;N. Engl. J. Med.,2005

3. First mature analysis of the Intergroup Exemestane Study;Coombes;J. Clin. Oncol.,2006

4. Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group;Mouridsen;J. Clin. Oncol.,2001

5. Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomised trial;Nabholtz;J. Clin. Oncol.,2000

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPRa screen identifies a role for c-KIT signaling in tamoxifen resistance, potentially through upregulation of ABC transporters;2022-08-22

2. Breast Cancer, Including Brief Discussion of Male Breast Cancer;The American Cancer Society's Oncology in Practice;2018-02-16

3. Impact of the OATP1B1 c.521T>C single nucleotide polymorphism on the pharmacokinetics of exemestane in healthy post-menopausal female volunteers;Journal of Clinical Pharmacy and Therapeutics;2017-07-29

4. COX2 induction: a mechanism of endocrine breast cancer resistance?;Breast Cancer Research and Treatment;2017-06-21

5. Phase 1b study of orteronel in postmenopausal women with hormone-receptor positive (HR+) metastatic breast cancer;Investigational New Drugs;2016-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3